drugset / Trial / NCT01490879

A Study to Investigate the Safety and Clinical Effect of Nexagon® as a Topical Treatment for Subjects With a Diabetic Foot Ulcer (DUNE)

NCT01490879 ↗

Phase 2 Completed 168 enrolled OcuNexus Therapeutics, Inc.
RandomizedParallel-groupTriple-blindTreatment

Summary

This study is for Type I or Type II diabetic subjects with with a diabetic foot ulcer. The study is being done to determine if Nexagon® plus standard of care is more effective than placebo plus standard of care. Standard of care will include debridement of the ulcer, standardized dressings and standardized off-loading using a Removable Cast Walker.

Timeline

Start
2012-07
Primary completion
2014-02
Completion
2014-04

Drugs

EvaluationDrugModalityDoseRoute
Subject CODA-001 Unknown — Topical

Indications